What is LOPJLB’s current signal on FBIO?

LOPJLB’s latest quantitative signal on Fortress Biotech, Inc. (FBIO) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is FBIO in?

Fortress Biotech, Inc. (FBIO) is currently classified in the CRISIS HMM market regime on LOPJLB.

Where is Fortress Biotech, Inc. based / listed?

Fortress Biotech, Inc. is based in US, listed on NASDAQ.

Fortress Biotech, Inc. (FBIO)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$2.13+1.91%Close

SELLCRISIS · day 22

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $71M
Beta: 1.19
P/E (TTM): 0.63

Short % float: 21.21%
Days to cover: 18.4
SI change: -4.1%

1W: +4.93%
1M: -17.12%

vs SPY 1W: +3.77%
vs SPY 1M: -20.11%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Fortress Biotech, Inc. operates as a biopharmaceutical firm dedicated to the development and commercialization of a diverse range of pharmaceutical and biotechnology products. The company currently offers a portfolio of dermatological treatments. These include Ximino and…

Employees: 78
Headquarters: US
Founded: 2011
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 33.2M
Float: 69.5%

fortressbiotech.com ↗

Key executives

Lindsay Allan Rosenwald — Executive Chairman, President & Chief Executive Officer

David Jin — Chief Financial Officer & Head of Corporate Development

Michael S. Weiss — Executive Vice Chairman of Strategic Development & Director

SEC filings

EDGAR · CIK 14292600 · FBIO

Analyst consensus

Buy

Bullish6100.0%

Neutral00.0%

Bearish00.0%

L $5.00Avg $5.00H $5.00

Target$5.00+134.74%

Last$2.13

Key stats

Prediction markets

Company news